Journal of Biological Chemistry 2001-04-27

The Bohr effect of hemoglobin intermediates and the role of salt bridges in the tertiary/quaternary transitions.

R Russo, L Benazzi, M Perrella

Index: J. Biol. Chem. 276(17) , 13628-34, (2001)

Full Text: HTML

Abstract

Understanding mechanisms in cooperative proteins requires the analysis of the intermediate ligation states. The release of hydrogen ions at the intermediate states of native and chemically modified hemoglobin, known as the Bohr effect, is an indicator of the protein tertiary/quaternary transitions, useful for testing models of cooperativity. The Bohr effects due to ligation of one subunit of a dimer and two subunits across the dimer interface are not additive. The reductions of the Bohr effect due to the chemical modification of a Bohr group of one and two alpha or beta subunits are additive. The Bohr effects of monoliganded chemically modified hemoglobins indicate the additivity of the effects of ligation and chemical modification with the possible exception of ligation and chemical modification of the alpha subunits. These observations suggest that ligation of a subunit brings about a tertiary structure change of hemoglobin in the T quaternary structure, which breaks some salt bridges, releases hydrogen ions, and is signaled across the dimer interface in such a way that ligation of a second subunit in the adjacent dimer promotes the switch from the T to the R quaternary structure. The rupture of the salt bridges per se does not drive the transition.


Related Compounds

  • Hemoglobin A0, Fe...

Related Articles:

Isolated Hb Providence β82Asn and β82Asp fractions are more stable than native HbA(0) under oxidative stress conditions.

2011-11-15

[Biochemistry 50(45) , 9752-66, (2011)]

Comparison of capillary electrophoregram among heterozygous Hb Hope, Hb Hope/α-thalassemia-1 SEA type deletion and Hb Hope/β(0)-thalassemia.

2012-01-01

[Clin. Chem. Lab Med. 50(9) , 1625-9, (2012)]

Effect of glycation of hemoglobin on its interaction with trifluoperazine.

2006-04-01

[Protein J. 25(3) , 202-11, (2006)]

Human hemoglobin shares bioactivities ascribed to human tumor necrosis factor-alpha.

2004-01-01

[Immunopharmacol. Immunotoxicol. 26(4) , 559-72, (2004)]

Chromatographic removal of endotoxin from hemoglobin preparations. Effects of solution conditions on endotoxin removal efficiency and protein recovery.

1998-06-05

[J. Chromatogr. A. 809(1-2) , 13-20, (1998)]

More Articles...